RSS Channels Index
Conference Explores Frontiers in Alzheimer’s, Lou Gehrig’s Diseases
At the Keystone Symposium “New Frontiers in Neurodegenerative Disease Research,” held 4-7 February in Santa Fe, New Mexico, researchers explored the processes that lead to a variety of diseases, including Alzheimer’s and Lou Gehrig’s disease...
3/6/2013 3:00 PM EST
Combination Drug Trials: Time to Open a New Front in AD?
Scientists are getting serious about tackling Alzheimer's disease with multiple drugs. Going after one target at a time has not proven successful, and some researchers believe that new drugs may not work well alone. Instead, they want to develop...
2/14/2013 12:00 PM EST
Meeting Probes Latest in Alzheimer’s Disease Imaging Research
At the 7th Human Amyloid Imaging conference held in Miami, Florida, 250 experts discussed the hottest topics in Alzheimer’s brain imaging. What’s in store for 2013? Read about new compounds that image tau—one of the disease’s toxic proteins,...
2/7/2013 10:30 AM EST
Exploring Deep Brain Stimulation for Parkinson's, Alzheimer's Diseases
Electrodes implanted inside the brain are helping patients with Parkinson's disease. Called deep brain stimulation, the treatment often gives patients control over their movements that cannot be achieved with currently approved drugs. But the...
1/16/2013 6:00 PM EST
A New Year’s Recap: The Twelve Trends of Alzheimer’s
Planning to cover dementia research this year? Before the 12 Days of Christmas are over, bone up on the most compelling research trends of 2012 by reading Alzforum’s roundup. It covers everything from surprising gene discoveries to drug trial...
1/3/2013 1:45 PM EST
Repeated Knocks to the Head Leads to Newly Recognized Brain Disease
Take a look inside the brains of many soldiers, football players, and boxers, and you’ll find shrinking structures and massive, spreading pathology. Scientists now realize the pattern looks different from any known neurodegenerative disease. A...
11/30/2012 10:35 AM EST
Alzheimer’s Drug Trials: Scientists Learn From The Old, Bring On The New
Potential Alzheimer’s disease drugs have performed poorly in clinical trials with no sign of any new approvals on the horizon. Have scientists reached a therapeutic dead end? Not according to the 5th Clinical Trials in Alzheimer’s Disease...
11/20/2012 1:55 PM EST
Alzheimer's Disease Prevention Trials Just Made a Leap Forward
Two pharma companies have agreed to donate three investigational drugs to test in people who are destined by genetics to develop early-onset Alzheimer's disease.
10/16/2012 6:00 PM EDT